SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001213900-17-012644
Filing Date
2017-11-28
Accepted
2017-11-27 18:07:03
Documents
2
Group Members
ABIR RAVEH

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D sc13d1117rimon_wizepharma.htm SC 13D 109191
2 JOINT FILING AGREEMENT BY AND AMONG THE REPORTING PERSONS sc13d1117ex14rimon_wizepha.htm EX-99.14 3113
  Complete submission text file 0001213900-17-012644.txt   113928
Mailing Address 5B HANAGAR STREET HOD HASHARON L3 4527708
Business Address 5B HANAGAR STREET HOD HASHARON L3 4527708 972 472 260 0536
Wize Pharma, Inc. (Subject) CIK: 0001218683 (see all company filings)

IRS No.: 880445167 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-82946 | Film No.: 171223775
SIC: 2834 Pharmaceutical Preparations

Mailing Address RAVEN RAVID & CO. 32A HABARZEL ST. TEL AVIV L3 6971047
Business Address RAVEN RAVID & CO. 32A HABARZEL ST. TEL AVIV L3 6971047 972-3-7676999
Rimon Gold Assets Ltd (Filed by) CIK: 0001721808 (see all company filings)

IRS No.: 514819424
Type: SC 13D